Acadia Healthcare Company, Inc. (BIT:1ACHC)
Italy · Delayed Price · Currency is EUR | Market Cap | 1.98B +13.7% |
| Revenue (ttm) | 2.92B +6.8% |
| Net Income | -960.14M |
| EPS | -10.62 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 16.55 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 21.20 |
| Previous Close | 21.60 |
| Day's Range | 21.20 - 21.20 |
| 52-Week Range | 9.90 - 25.40 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About Acadia Healthcare Company
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and i... [Read more]
News
Acadia Healthcare Company Earnings Call Transcript: Q1 2026
Revenue and Adjusted EBITDA exceeded guidance in Q1 2026, driven by strong acute and RTC performance. Full-year Adjusted EBITDA and EPS guidance were raised, while operational improvements and leadership changes support continued growth.
Acadia Healthcare Company Earnings release: Q1 2026
Acadia Healthcare Company released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Acadia Healthcare Company Slides: Q1 2026
Acadia Healthcare Company has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Acadia Healthcare Company Quarterly report: Q1 2026
Acadia Healthcare Company has published its Q1 2026 quarterly earnings report on April 30, 2026.
Acadia Healthcare Announces First Quarter 2026 Results
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026. First Quarter...
Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadi...
David Einhorn signals caution as his hedge fund Greenlight prioritizes capital protection
Greenlight Capital's David Einhorn warned that investors may be underestimating potential downside risks. "It probably won't surprise anyone that we are again putting capital preservation at the top o...
Acadia Healthcare Announces Date for First Quarter 2026 Earnings Release
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its first quarter 2026 results on Wednesday, April 29, 2026, after the close of th...
Acadia Healthcare Company Proxy statement: Proxy filing
Acadia Healthcare Company filed a proxy statement on March 25, 2026, providing details for shareholder voting and corporate governance matters.
Acadia Healthcare Company Proxy statement: Proxy filing
Acadia Healthcare Company filed a proxy statement on March 25, 2026, providing details for shareholder voting and corporate governance matters.
Acadia Healthcare Appoints Daniel Cancelmi to Board of Directors
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia”) today announced that it has appointed Daniel Cancelmi to its Board of Directors, effective immediately. Mr. ...
Acadia Healthcare Company Transcript: Barclays 28th Annual Global Healthcare Conference
Leadership changes have energized operations, with a focus on filling 3,000 new beds and improving execution. Demand remains strong, but policy changes and payer scrutiny present headwinds. Expense management and capital deployment prioritize debt reduction and operational efficiency.
Acadia Healthcare Company Transcript: Leerink Global Healthcare Conference 2026
Leadership is driving organizational changes to improve execution and facility performance, with a focus on maximizing existing assets and reducing costs. Financial guidance is conservative, prioritizing debt reduction as CapEx declines, while risk management addresses rising malpractice claims and payer challenges.
Acadia Healthcare Company Transcript: 47th Annual Raymond James Institutional Investor Conference
A leading behavioral health provider outlined its focus on patient care, operational excellence, and ramping new bed capacity, with 2026 revenue guidance of $3.37–$3.45 billion and significant CapEx reductions. Quality outcomes and payer relationships are key, while legal expenses are expected to decline.
Acadia Healthcare Company Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 saw solid revenue and EBITDA growth, with expansion through joint ventures and disciplined capital allocation. 2026 guidance anticipates modest volume growth, lower CapEx, and a focus on operational excellence amid regulatory and payer headwinds, especially from New York Medicaid changes.
Acadia Healthcare Company Annual report: Q4 2025
Acadia Healthcare Company has published its Q4 2025 annual report on February 25, 2026.
Acadia Healthcare Company Earnings release: Q4 2025
Acadia Healthcare Company released its Q4 2025 earnings on February 25, 2026, summarizing the period's financial results.
Acadia Healthcare Company Slides: Q4 2025
Acadia Healthcare Company has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 25, 2026.
Acadia Healthcare Announces Fourth Quarter and 2025 Results
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025. ...
Acadia Healthcare to Participate in March Investor Conferences
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March. On Monday, March 2, 2026, the...
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2025 Earnings Release
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, befo...
Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive Office...
Acadia Healthcare Company Transcript: 44th Annual J.P. Morgan Healthcare Conference
The conference highlighted strong operational progress, significant bed growth, and ongoing investments in quality and technology. Despite 2025 financial headwinds from payer pressure and regulatory changes, the company expects ramping new facilities, reduced CapEx, and enhanced execution to drive EBITDA and free cash flow growth in 2026 and beyond.
Acadia Healthcare Company Slides: 44th Annual J.P. Morgan Healthcare Conference
Acadia Healthcare Company has posted slides in relation to its latest quarterly earnings report, which was published on January 13, 2026.
Acadia Healthcare to Participate in 44th Annual J.P. Morgan Healthcare Conference
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference, January 12-15, ...